The necessity of holistic approach to treatment of telogen hair loss associated with iron deficiency in women
- 作者: Gaydina T.A.1, Shcherbina S.A.1, Skripkina P.A.1, Silin A.A.1
-
隶属关系:
- Pirogov Russian National Research Medical University
- 期: 卷 96, 编号 5 (2020)
- 页面: 39-46
- 栏目: CLINICAL PRACTICE GUIDELINES
- URL: https://ogarev-online.ru/0042-4609/article/view/117538
- DOI: https://doi.org/10.25208/vdv539-2020-96-5-39-46
- ID: 117538
如何引用文章
全文:
详细
The relationship between disorders of iron metabolism and alopecia, in particular telogen hair loss (THL), remains poorly understood and requires further research.
Goal. To assess changes in the dynamics of growth and hair condition in women with an iron deficiency state during systemic therapy with iron supplements in combination with and without physiotherapy.
Methods. An open-label, randomized, comparative interventional study with a duration of 6 months included 26 female aged 19 to 54 years (38.8 ± 8.9 years) with complaints of hair loss, changes in their structure, dryness and / or hair brittleness; with preserved menstrual cycle and mild iron deficiency anemia (IDA, Hb 101–120 g/l). Trichoscopy and phototrichogram were performed with processing of the results in the TrichoScienceProv1.1 program. The changes in the dynamics of hair growth and condition were assessed against the background of the use of iron supplements in combination with physiotherapy and without physiotherapy. Pulsed alternating sinusoidal current of high frequency, high voltage and low strength was chosen as a physiotherapeutic method for the treatment of THL.
Results. Against the background of the therapy, an increase in the Hb level (p < 0.001) and a positive dynamics of trichological parameters in all patients were noted, the severity of which was higher when the therapy with iron supplements was combined with physiotherapy.
Conclusion. Our findings confirm that the complex treatment of patients with telogen alopecia on the background of an iron deficiency state may achieve positive dynamics of trichological indicators.
作者简介
T. Gaydina
Pirogov Russian National Research Medical University
编辑信件的主要联系方式.
Email: doc429@yandex.ru
ORCID iD: 0000-0001-8485-3294
К.м.н., доцент кафедры дерматовенерологии лечебного факультета
俄罗斯联邦S. Shcherbina
Pirogov Russian National Research Medical University
Email: doc429@yandex.ru
俄罗斯联邦
P. Skripkina
Pirogov Russian National Research Medical University
Email: doc429@yandex.ru
К.м.н., доцент кафедры дерматовенерологии лечебного факультета
俄罗斯联邦A. Silin
Pirogov Russian National Research Medical University
Email: doc429@yandex.ru
俄罗斯联邦
参考
- Кубанов А.А., Галлямова Ю.А., Селезнева О.А. Исследование эффективности комплексной терапии выпадения волос. Вестник дерматологии и венерологии. 2016;(1):32–46. [Kubanov AA, Galljamova JA, Selezneva OA. Efficiency research of the comprehensive hair loss treatment. Vestnik dermatologii i venerologii. 2016;(1):32–46 (In Russ.)]
- Vano-Galvan S, Saceda-Corralo D, Blume-Peytavi U, Cucchía J, Dlova NC, Gavazzoni Dias MFR, et al. Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study. Skin Appendage Disorders. 2019;5(5):309–315. doi: 10.1159/000496708
- Ozay O, Arslantas D, Unsal A, Bulur I. The frequency of alopecia and quality of life in high-school students in rural areas (Sivrihisar, Mahmudiye, Alpu, and Beylikova) of Eskisehir. Northern Clinics of Istanbul. 2019;6(3):226–235. doi: 10.14744/nci.2018.59365
- Звездина И.В., Исаева С.Г., Ляпон А.О. Новый взгляд на терапию хронической идиопатической диффузной телогеновой алопеции у женщин. Доктор.ру. 2015;7(108):42–46. [Zvezdina IV, Isaeva SG, Lyapon AO. New Insight into Treating Chronic Idiopathic Diffuse Telogen Effluvium in Women. Doktor.ru. 2015;7(108):42–46 (In Russ.)]
- Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The Role of Vitamins and Minerals in Hair Loss: A Review. Dermatology and therapy. 2019;9(1):51–70. doi: 10.1007/s13555-018-0278-6
- Vinay K, Sawatkar GU, Dogra S. Hair manifestations of endocrine diseases: A brief review. Indian Journal of Dermatology, Venereology, and Leprology. 2018;84(5):528–538. doi: 10.4103/ijdvl.IJDVL_671_17
- Phillips TG, Slomiany WP, Allison R. Hair Loss: Common Causes and Treatment. American Family Physician. 2017;96(6):371–378.
- Rebora A. Telogen effluvium: a comprehensive review. Clinical, cosmetic and investigational dermatology. 2019;(12):583–590. doi: 10.2147/CCID.S200471
- Ghias MH, Amin BD, Kutner AJ. Albendazole-induced anagen effluvium Journal of the American Academy of Dermatology Case Reports. 2020;6(1):54–56. doi: 10.1016/j.jdcr.2019.08.010
- Chu CB, Yang CC. Dengue-associated telogen effluvium: A report of 14 patients. Dermatologica Sinica. 2017;35(3):124–126.
- Guzman-Sanchez D, Asz-Sigall D. Alopecias due to drugs and other skin and systemic disorders. Current problems in dermatology. 2015;47:97–106. doi: 10.1159/000369409
- Кубанов А.А., Галлямова Ю.А., Селезнева О.А. Динамика показателей трихоскопии и фототрихографии у больных нерубцовыми алопециями на фоне комплексного лечения. Лечащий врач. 2016;(5):45. [Kubanov AA, Gallyamova YA, Selezneva OA. Dinamika pokazateley trikhoskopii i fototrikhografii u bolnykh nerubtsovymi alopetsiyami na fone kompleksnogo lecheniya. Lechashchiy vrach. 2016;(5):45 (In Russ.)]
- Daly T, Daly K. Telogen effluvium with dysesthesia (TED) has lower B12 levels and may respond to B12 supplementation. Journal of drugs in dermatology. 2018;17(11):1236–1240.
- Karashima T, Tsuruta D, Hamada T, Ono F, Ishii N, Abe T, et al. Oral zinc therapy for zinc deficiency-related telogen effluvium. Dermatologic therapy. 2012;25(2):210–213. doi: 10.1111/j.1529-8019.2012.01443.x
- Олисова О.Ю., Егорова К.Г. Богатая тромбоцитами плазма в терапии нерубцовых алопеций. Российский журнал кожных и венерических болезней. 2014;17(6):60–62. [Olisova OY, Egorova KG. Platelet-rich plasma in therapy of nonscarring alopecia. Russian journal of skin and venereal diseases. 2014;17(6):60–62 (In Russ.)]
- Скадорва В.В. Патогенез, диагностика и лечение диффузной алопеции. Здравоохранение. 2016;(7):31–38. [Skadorva VV. Diffuse alopecia pathogenesis, diagnosis and treatment. Healthcare. 2016;(7):31–38 (In Russ.)]
- Rangwala S, Rashid RM. Alopecia: a review of laser and light therapies. Dermatology online journal. 2012;18(2):3.
- Malkud S. Telogen Effluvium: A Review. Journal of clinical and diagnostic research. 2015;9(9):WE01-WE03. doi: 10.7860/JCDR/2015/15219.6492
- Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol. International Journal of Women's Dermatology. 2018;5(1):46–51. doi: 10.1016/j.ijwd.2018.08.004
- Trüeb RM, Jolliffe VML, Régnier AF, Dutra Rezende H, Vañó-Galván S, Kopera D, et al. Precision Medicine and the Practice of Trichiatry: Adapting the Concept. Skin Appendage Disorders. 2019;5(6):338–343. doi: 10.1159/000500364
- Беречикидзе Т.Т., Пинегин В.Б. Диффузная телогеновая алопеция. Новые возможности коррекции. Российский журнал кожных и венерических болезней. 2016;19(3):162–166. [Berechikidze TT, Pinegin VB. Diffuznaya telogenovaya alopetsiya. Novye vozmozhnosti korrektsii. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2016;19(3):162–166 (In Russ.)]
- World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: WHO; 2011.
- Camaschella C. Iron deficiency. Blood. 2019;133(1):30–39. doi: 10.1182/blood-2018-05-815944
- Gowda D, Premalatha V, Imtiyaz DB. Prevalence of nutritional deficiencies in hair loss among Indian participants: Results of a cross-sectional study. International journal of trichology. 2017;9(3):101–104. doi: 10.4103/ijt.ijt_48_16
- Deo K, Sharma Y, Wadhoka, M, Tyagi N. Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function. Dermatology Research and Practice. 2016;(1):1–5. doi: 10.1155/2016/6279108
- Grover C, Khurana A. Telogen effluvium. Indian journal of dermatology, venereology and leprology. 2013;79(5):591–603. doi: 10.4103/0378-6323.116731
- Perez-Mora N, Goren A, Velasco C, Bermudez F. Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. Dermatologic therapy. 2014;27(3):159–162. doi: 10.1111/dth.12101
- Trüeb RM. Effect of ultraviolet radiation, smoking and nutrition on hair. Current problems in dermatology. 2015;47:107–120. doi: 10.1159/000369411
- Moeinvaziri M, Mansoori P, Holakooee K, Safaee Naraghi Z, Abbasi A. Iron status in diffuse telogen hair loss among women. Acta dermatovenerologica Croatica. 2009;17(4):279–284.
- Poonia K, Thami GP, Bhalla M, Jaiswal S, Sandhu J. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. Journal of Cosmetic Dermatology. 2019;18(1):401–407. doi: 10.1111/jocd.12559
- Bregy A, Trüeb RM. No Association between Serum Ferritin Levels >10 μg/l and Hair Loss Activity in Women. Dermatology. 2008;217(1):1–6. doi: 10.1159/000118505
- Trüeb R. Telogen Effluvium: Is There a Need for a New Classification? Skin Appendage Disorder. 2016;2:39–44. doi: 10.1159/000446119
- Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. Journal of the American Academy of Dermatology. 2010;63(6):991–999. doi: 10.1016/j.jaad.2009.12.006
- Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320(5879):1088–1092. doi: 10.1126/science.1157121
补充文件
